These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11065349)

  • 1. Renal transfer of genetically engineered cells.
    Kitamura M
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S154-8. PubMed ID: 11065349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of genetically engineered cells to the glomerulus.
    Kitamura M
    Exp Nephrol; 1999; 7(3):259-66. PubMed ID: 10352367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene delivery into the renal glomerulus by transfer of genetically engineered, autologous mesangial cells.
    Kitamura M; Burton S; Yokoo T; Fine LG
    Exp Nephrol; 1996; 4(1):56-9. PubMed ID: 8788601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of interleukin-1 receptor antagonist into the renal glomerulus via a mesangial cell vector.
    Yokoo T; Kitamura M
    Biochem Biophys Res Commun; 1996 Sep; 226(3):883-8. PubMed ID: 8831705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome.
    Heikkila P; Parpala T; Lukkarinen O; Weber M; Tryggvason K
    Gene Ther; 1996 Jan; 3(1):21-7. PubMed ID: 8929908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer into the rat renal glomerulus via a mesangial cell vector: site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo.
    Kitamura M; Taylor S; Unwin R; Burton S; Shimizu F; Fine LG
    J Clin Invest; 1994 Aug; 94(2):497-505. PubMed ID: 8040302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive transfer of nuclear factor-kappaB-inactive macrophages to the glomerulus.
    Kitamura M
    Kidney Int; 2000 Feb; 57(2):709-16. PubMed ID: 10652050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer into inflamed glomeruli using macrophages transfected with adenovirus.
    Kluth DC; Erwig LP; Pearce WP; Rees AJ
    Gene Ther; 2000 Feb; 7(3):263-70. PubMed ID: 10694804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The glomerular mesangium: a new perspective on its structure and function].
    Rodríguez JH; Méndez Sánchez A; Blanco Rodríguez A; Moyano Navarro T; Gómez-Villamandos JC
    Arch Esp Urol; 1995 Apr; 48(3):229-33. PubMed ID: 7755428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
    Huijun W; Long C; Zhigang Z; Feng J; Muyi G
    Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time monitoring of mesangial cell-macrophage cross-talk using SEAP in vitro and ex vivo.
    Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Takeda M; Shimizu F; Kawachi H; Yao J; Kitamura M
    Kidney Int; 2005 Aug; 68(2):886-93. PubMed ID: 16014070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets.
    Burke B; Sumner S; Maitland N; Lewis CE
    J Leukoc Biol; 2002 Sep; 72(3):417-28. PubMed ID: 12223508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene delivery into rat glomerulus using a mesangial cell vector.
    Kim HJ; Kim SI; Yun IJ; Kwak JH; Yu SH
    Mol Cells; 2000 Dec; 10(6):662-8. PubMed ID: 11211871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivering erythropoietin through genetically engineered cells.
    Bohl D; Heard JM
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S159-62. PubMed ID: 11065350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting genetically modified macrophages to the glomerulus.
    Wilson HM; Kluth DC
    Nephron Exp Nephrol; 2003; 94(4):e113-8. PubMed ID: 12972709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer to the rat kidney in vivo and ex vivo using an adenovirus vector: factors influencing transgene expression.
    Fujishiro J; Takeda S; Takeno Y; Takeuchi K; Ogata Y; Takahashi M; Hakamata Y; Kaneko T; Murakami T; Okada T; Ozawa K; Hashizume K; Kobayashi E
    Nephrol Dial Transplant; 2005 Jul; 20(7):1385-91. PubMed ID: 15871986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesangial cell-predominant functional gene, megsin.
    Inagi R; Nangaku M; Miyata T; Kurokawa K
    Clin Exp Nephrol; 2003 Jun; 7(2):87-92. PubMed ID: 14586725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring RNA interference as a therapeutic strategy for renal disease.
    Takabatake Y; Isaka Y; Mizui M; Kawachi H; Shimizu F; Ito T; Hori M; Imai E
    Gene Ther; 2005 Jun; 12(12):965-73. PubMed ID: 15729369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus.
    Kitamura M
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7387-91. PubMed ID: 8693003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
    Kunter U; Rong S; Djuric Z; Boor P; Müller-Newen G; Yu D; Floege J
    J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.